Pfizer projects it will generate record-high revenue in 2022, saying Tuesday it expects to sell $32 billion of its COVID-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid this year.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
